| Literature DB >> 26977177 |
Daniel I Hădărugă1, Mustafa Ünlüsayin2, Alexandra T Gruia3, Cristina Birău Mitroi4, Gerlinde Rusu1, Nicoleta G Hădărugă4.
Abstract
The thermal and oxidative stability of Atlantic salmon oil (Salmo salar L.) as well as its β-cyclodextrin (β-CD) complexation ability has been verified for the first time. The main omega-3 fatty acids, EPA and DHA, were significantly degraded, even at 50 °C. Their relative concentrations decrease from 6.1% for EPA and 4.1% for DHA to 1.7% and 1.5% after degradation at 150 °C, respectively. On the other hand, the relative concentrations of monounsaturated and saturated fatty acids remained constant or slightly increased by a few percent after degradation (e.g., from 10.7% to 12.9% for palmitic acid). Co-crystallization of ASO with β-CD at a host-guest ratio of 1:1 and 3:1 from an ethanol-water mixture and kneading methods has been used for the preparation of β-CD/ASO complexes. The analysis of the complexes by thermogravimetry, differential scanning calorimetry (DSC), and Karl Fischer titration (KFT) as well as the decrease of the "strongly-retained" water content confirm the formation of the inclusion compound. Furthermore, the DSC parameters correlate well with the KFT kinetic data for β-CD/ASO complexes.Entities:
Keywords: Atlantic salmon oil (ASO); Karl Fischer titration; differential scanning calorimetry; omega-3 fatty acid; thermogravimetry; β-cyclodextrin
Year: 2016 PMID: 26977177 PMCID: PMC4778528 DOI: 10.3762/bjoc.12.20
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.883
Relative concentrations of FAs (as methyl esters) obtained from the GC–MS analysis of the derivatized, raw, Atlantic salmon oil (ASO) and those degraded at low (50 °C, code ASO50) and high (150 °C, code ASO150) temperatures.
| Entry | Namea | KIb | Codec | Classd | Area (ASO) (%)e | Area (ASO50) (%)e | Area (ASO150) (%)e |
| 1 | Myristic | 1734 | C14:0 | SFA | 3.46 ± 0.301 | 3.34 ± 0.203 | 3.33 ± 0.727 |
| 2 | Pentadecanoic | 1835 | C15:0 | SFA | 0.23 ± 0.012 | 0.36 ± 0.079 | 0.43 ± 0.009 |
| 3 | 7,10,13-Hexadecatrienoic | 1900 | C16:3 | PUFA | 0.31 ± 0.003 | 0.27 ± 0.045 | 0.46 |
| 4 | Palmitoleic | 1916 | C16:1 | MUFA | 3.50 ± 0.091 | 3.31 ± 0.215 | 2.84 ± 0.831 |
| 5 | Palmitic | 1941 | C16:0 | SFA | 10.69 ± 0.78 | 11.35 ± 0.35 | 12.94 ± 2.26 |
| 6 | Margaric | 2039 | C17:0 | SFA | 0.14 ± 0.006 | 0.20 | – |
| 7 | Polyunsaturated fatty acidf | 2096 | C20:4# | PUFA | 1.35 ± 0.025 | 0.78 ± 0.135 | – |
| 8 | Linoleic | 2108 | C18:2 | PUFA | 11.20 ± 0.29 | 11.29 ± 0.11 | 9.10 ± 2.19 |
| 9 | Oleic | 2121 | C18:1 | MUFA | 35.60 ± 1.77 | 37.64 ± 0.39 | 35.08 ± 6.85 |
| 10 | Stearic | 2148 | C18:0 | SFA | 2.68 ± 0.082 | 2.79 ± 0.060 | 3.13 ± 0.645 |
| 11 | Polyunsaturated fatty acidf | 2165 | C20:4# | PUFA | 0.13 ± 0.038 | – | – |
| 12 | Monounsaturated fatty acidf | 2190 | C18:1# | MUFA | 0.69 ± 0.402 | 2.56 ± 0.034 | 3.09 |
| 13 | Nonadecanoic | 2255 | C19:0 | SFA | – | – | – |
| 14 | EPA (5,8,11,14,17-eicosapentaenoic) | 2309 | C20:5 | PUFA | 6.10 ± 0.378 | 2.17 ± 0.370 | 1.74 ± 0.783 |
| 15 | Polyunsaturated fatty acidf | 2322 | C20:3# | PUFA | 0.84 ± 0.179 | 0.37 | 1.16 |
| 16 | 11-Eicosenoic | 2347 | C20:1 | MUFA | 0.62 ± 0.015 | 0.48 ± 0.014 | – |
| 17 | Polyunsaturated fatty acidf | 2404 | C20:5# | PUFA | – | – | – |
| 18 | Polyunsaturated fatty acidf | 2429 | C20:5# | PUFA | – | – | – |
| 19 | Polyunsaturated fatty acidf | 2523 | C20:5# | PUFA | – | – | – |
| 20 | DHA (4,7,10,13,16,19-docosahexaenoic) | 2573 | C22:6 | PUFA | 4.13 ± 0.731 | 1.70 ± 0.315 | 1.45 ± 0.482 |
| 21 | Polyunsaturated fatty acidf | 2591 | C20:5# | PUFA | 1.37 ± 0.211 | – | – |
| 22 | Polyunsaturated fatty acidf | 2709 | C20:5# | PUFA | – | – | – |
| 23 | Erucic | 2784 | C22:1 | MUFA | 1.57 | 2.45 ± 0.322 | 1.73 ± 0.445 |
| 24 | Behenic | 2855 | C22:0 | SFA | – | – | – |
| 25 | Nervotic | 3173 | C24:1 | MUFA | – | – | – |
| 26 | Other minor compoundsg | 15.39 | 18.94 | 23.52 | |||
| Total quantified FAs (%) | 84.61 | 81.06 | 76.48 | ||||
| Total SFAs (%) | 17.2 | 18.04 | 19.83 | ||||
| Total MUFAs (%) | 41.98 | 46.44 | 42.74 | ||||
| Total PUFAs (%) | 25.43 | 16.58 | 13.91 | ||||
aThe FAME name; bKovats index (calculated according to C8–C20 alkane standard solution GC data; higher KI values were obtained by extrapolation); cthe corresponding FA code (Cx:y represents the fatty acid containing “x” carbon atoms and “y” double bonds; dSFA – saturated fatty acid, MUFA – monounsaturated fatty acid, PUFA – polyunsaturated fatty acid; ethe FAME concentration, calculated as the percent ratio between the GC peak area of the compound and the sum of all GC peak areas; fisomers are indicated by “#” (using only the MS data and not the standard FAMEs); gthe other minor compounds were FAMEs having concentrations lower than 0.05% or they do not belong to this class (e.g., aldehydes).
Figure 1Superimposed thermograms for β-CD (solid line) and (a) β-CD/ASO_1:1_a&b (duplicate) or (b) β-CD/ASO_3:1_a&b (duplicate). For sample name abbreviations, see Table 3.
Abbreviations used.
| Abbreviation | Full text |
| ANOVA | analysis of variance |
| ASO | Atlantic salmon oil |
| β-CD | β-cyclodextrin |
| β-CD/ASO_1:1_a&b | β-cyclodextrin/Atlantic salmon oil complex obtained by co-crystallization at a 1:1 molar ratio (duplicates “a” and “b”) |
| β-CD/ASO_1:1(k)_a&b | β-cyclodextrin/Atlantic salmon oil complex obtained by kneading at a 1:1 molar ratio (duplicates “a” and “b”) |
| β-CD/ASO_3:1_a&b | β-cyclodextrin/Atlantic salmon oil complex obtained by co-crystallization at a 3:1 molar ratio (duplicates “a” and “b”) |
| β-CD/ASO_3:1(k)_a&b | β-cyclodextrin/Atlantic salmon oil complex obtained by kneading at a 3:1 molar ratio (duplicates “a” and “b”) |
| BHT | butylated hydroxytoluene |
| DHA | (all- |
| DSC | differential scanning calorimetry |
| EPA | (all- |
| FA | fatty acid |
| FAME | fatty acid methyl ester |
| GC–MS | gas chromatography–mass spectrometry |
| KFT | Karl Fischer titration |
| KI | Kovats index |
| LDL | low-density lipoprotein |
| MLN | methylated linolenic acid |
| MUFA | monounsaturated fatty acid |
| PUFA | polyunsaturated fatty acid |
| SFA | saturated fatty acid |
| TG | thermogravimetry |
Figure 2Superimposed DSC data for β-CD (solid line) and (a) β-CD/ASO_3:1_a&b (duplicate) or (b) β-CD/ASO_3:1(k)_a&b (duplicate). For sample name abbreviations, see Table 3.
Water content and mean water reaction rates, ν, in the main time ranges (10–30 s and 30–90 s) of β-CD/ASO complexes and commercial β-CD obtained by the KFT method.
| Entry | Code | Water content (%) | “Surface” water reaction rate, ν1 (mM·s−1)a | “Strongly-retained” water reaction rate, ν2 (mM·s−1)a |
| 1 | β-CD | 13.69 ± 0.21b | 0.445 ± 0.136 | 0.055 ± 0.017 |
| 2 | β-CD/ASO_1:1_a | 7.49 ± 0.67c | 0.039 ± 0.006 | 0.025 ± 0.002 |
| 3 | β-CD/ASO_1:1_b | 7.11 ± 0.57d | 0.034 ± 0.003 | 0.021 ± 0.002 |
| 4 | β-CD/ASO_3:1_a | 9.06 ± 0.22e | 0.109 ± 0.011 | 0.036 ± 0.005 |
| 5 | β-CD/ASO_3:1_b | 8.85 ± 0.25d | 0.124 ± 0.026 | 0.033 ± 0.004 |
| 6 | β-CD/ASO_1:1(k)_a | 8.88 ± 0.29c | 0.146 ± 0.021 | 0.034 ± 0.006 |
| 7 | β-CD/ASO_1:1(k)_b | 8.31 ± 0.25d | 0.049 ± 0.011 | 0.026 ± 0.004 |
| 8 | β-CD/ASO_3:1(k)_a | 11.84 ± 0.19d | 0.198 ± 0.020 | 0.021 ± 0.003 |
| 9 | β-CD/ASO_3:1(k)_b | 11.36 ± 0.26c | 0.181 ± 0.034 | 0.053 ± 0.006 |
aν1 and ν2 represent the mean water reaction rates from the KFT analysis for the time intervals corresponding to “surface” water (10–30 s) and “strongly-retained” water molecules (30–90 s), respectively; the number of replicates were beight, csix, dseven and efive.
Figure 3The equation of the KF chemical reaction.
Figure 4Superimposed volume versus time linear correlations (all three specific intervals) from the KFT analysis of β-CD/ASO_1:1 (only the second replicate “b” of the complex is presented; there are seven determinations).
Figure 5Superimposed volume versus time linear correlations (all three specific intervals) from the KFT analysis of β-CD/ASO_3:1(k) (only the second replicate “b” of the complex is presented; there are six determinations).